Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Neoplasms 15Uterine Cervical Neoplasms 12Carcinoma, Non-Small-Cell Lung 10Melanoma 9Triple Negative Breast Neoplasms 7Endometrial Neoplasms 7Stomach Neoplasms 6Carcinoma, Transitional Cell 6Carcinoma, Renal Cell 6Squamous Cell Carcinoma of Head and Neck 5Small Cell Lung Carcinoma 5Fallopian Tube Neoplasms 5Colorectal Neoplasms 4Carcinoma, Merkel Cell 4Carcinoma, Hepatocellular 4Neoplasm Metastasis 3Mesothelioma 3Esophageal Neoplasms 3Cholangiocarcinoma 3Vulvar Neoplasms 2Urinary Bladder Neoplasms 2Seminoma 2Sarcoma 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Neoplasms 2Nasopharyngeal Carcinoma 2Lung Neoplasms 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Myeloid, Acute 2

Interventions

Paclitaxel 2Nivolumab 2Gemcitabine 2Bevacizumab 2rucaparib 1pembrolizumab 1liposomal doxorubicin 1dostarlimab 1Taxes 1Sunitinib 1Ipilimumab 1Immunoglobulin G 1Doxorubicin 1Docetaxel 1Disulfides 1Celecoxib 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma, Clear Cell × Ipilimumab × Gynecologic × Clear all
NCT03355976 2026-04-02

BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas

Brown University

Phase 2 Active not recruiting
46 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence, Adenocarcinoma, Clear Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡